Related Experiment Video

Updated: Sep 4, 2025

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
08:08

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

102.5K

The iterative process of fluid biomarker development and validation in Alzheimer's disease

Barbara B Bendlin1,2,3,4, Henrik Zetterberg5,6,7,8,9

  • 1Center for Health Disparities Research University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.

Alzheimer'S & Dementia (Amsterdam, Netherlands)
|July 18, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

63.5K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

332

Related Experiment Videos

Last Updated: Sep 4, 2025

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
08:08

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

102.5K
An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

63.5K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

332

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663

Articles linked to this work by shared authors, journal, and citation graph.

The role of vascular risk factors in white matter tract microstructure: a multi-cohort study in older adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Better cardiovascular health, measured by Life's Simple 7, is associated with lower white matter hyperintensity burden and greater cerebral blood flow over time.

Journal of Alzheimer's disease : JAD·2026

Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology.

Nature communications·2026

Tree-Structured Orthonormal Decomposition of the Aitchison Simplex.

ArXiv·2026

Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Virtual reality-based cognitive-motor training in middle-aged adults at high Alzheimer's disease risk improves frontal cortex cerebral blood flow: A randomized controlled trial.

Alzheimer's & dementia (New York, N. Y.)·2026

Clinical impact of amyloid PET in memory clinic: A 2-year longitudinal real-world study in Taiwan.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

MMSE-CDR-SB residual as an exploratory indicator of deviation from an Alzheimer's disease-typical cognitive-functional pattern.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Associations between essential trace elements and Alzheimer's disease and related dementias.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Structural MRI signature predicts tau staging in Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Decreased cerebral metabolic rate of oxygen (CMRO2) is associated with increased tau deposition in Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Organ-specific transcriptional programs regulate cellular plasticity in lymphatic endothelial cells.

Biochemical and biophysical research communications·2026

Simulating Thermoresponsive Behavior of Disordered Proteins with Temperature-Dependent Coarse-Grained Potentials Derived from Hydration Free Energies.

JACS Au·2026

Evaluation of Aquaporin-Incorporated Forward Osmosis Membrane and Biofilm Carrier Materials in a Novel Osmotic Membrane Bioreactor for Low-Temperature Rural Sewage Treatment.

Materials (Basel, Switzerland)·2026

Leptomeningeal fibroblasts promote glioblastoma progression by regulating cerebrospinal fluid dynamics.

Nature communications·2026

Silica Nanoparticle-Reinforced Wormlike Micellar Gels for High-Temperature Flow Redistribution in Heterogeneous Porous Media.

Gels (Basel, Switzerland)·2026

Different Alginate Spherification Methods for Producing Hydrogel Beads Loaded with Vitamins B9 and B12 to Support Hydration in Older Adults with Dysphagia.

Gels (Basel, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us